Evidence map›Paper›PMID 33920383›Full record

ArticleInternational journal of environmental research and public health2021

Development of a Questionnaire for the Search for Occupational Causes in Patients with Non-Hodgkin Lymphoma: The RHELYPRO Study.

Mireille Matrat, Murielle Gain, Corinne Haioun, Fabien Le Bras, Catherine Nisse, Franck Morschhauser, Bénédicte Clin, Isabelle Baldi, Catherine Verdun-Esquer, Robert Garnier and 9 more

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Mireille MatratService des Pathologies Professionnelles et de l'Environnement, CHI Créteil, F-94010 Créteil, France.
Murielle GainService des Pathologies Professionnelles et de l'Environnement, CHI Créteil, F-94010 Créteil, France.
Corinne HaiounINSERM, IMRB, Paris Est Créteil University, F-94010 Créteil, France.ORCID 0000-0003-0095-5379
Fabien Le BrasAP-HP, Hôpital Henri Mondor, Unité Hémopathies Lymphoïdes, F-94010 Créteil, France.
Catherine NisseCHU Lille, Institut Pasteur de Lille, Université de Lille, 4483-IMPECS-Impact de l'environnement Chimique sur la Santé Humaine, F-59000 Lille, France.ORCID 0000-0003-2035-9574
Franck MorschhauserULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Université de Lille, CHU Lille, F-59000 Lille, France.
Bénédicte ClinCentre Régional de Pathologies Professionnelles et Environnementales, CHU de Caen, INSERM U1086, Cancers et Préventions, Université de Caen Normandie, F-14033 Caen, France.ORCID 0000-0001-9138-5265
Isabelle BaldiService Santé Travail Environnement, CHU Bordeaux, INSERM U1219, EPICENE, Bordeaux University, F-33076 Bordeaux, France.
Catherine Verdun-EsquerService Santé Travail Environnement, CHU Bordeaux, INSERM U1219, EPICENE, Bordeaux University, F-33076 Bordeaux, France.ORCID 0000-0003-3396-7608
Robert GarnierCentre Antipoison de Paris, Consultation de Pathologie Professionnelle et de l'Environnement, AP-HP, Nord-Université de Paris, Hôpital Lariboisière-Fernand Widal-St Louis, F-75475 Paris, France.ORCID 0000-0002-6318-7058
Hervé Laborde-CastérotCentre Antipoison de Paris, Consultation de Pathologie Professionnelle et de l'Environnement, AP-HP, Nord-Université de Paris, Hôpital Lariboisière-Fernand Widal-St Louis, F-75475 Paris, France.ORCID 0000-0001-7151-1586
Fabrice HérinCentre Régional de Pathologies Professionnelles et Environnementales, CHU Toulouse, F-31059 Toulouse, France.
Yolande EsquirolCentre Régional de Pathologies Professionnelles et Environnementales, CHU Toulouse, F-31059 Toulouse, France.
Pascal AndujarService des Pathologies Professionnelles et de l'Environnement, CHI Créteil, F-94010 Créteil, France.
Milia BelacelInstitut Santé-Travail Paris-Est, CHI Créteil, F-94010 Créteil, France.
Christos ChouaïdCentre de Recherche Clinique, CHI Créteil, F-94010 Créteil, France.ORCID 0000-0002-4290-5524
Claire ChauvetAnses, Agence Nationale de Sécurité Sanitaire de l'alimentation, de l'environnement et du Travail, F-94700 Maisons-Alfort, France.
Gérard LasfarguesAnses, Agence Nationale de Sécurité Sanitaire de l'alimentation, de l'environnement et du Travail, F-94700 Maisons-Alfort, France.
Jean-Claude PaironService des Pathologies Professionnelles et de l'Environnement, CHI Créteil, F-94010 Créteil, France.ORCID 0000-0002-4323-6406
Inserm · FRHôpital Intercommunal de Créteil · FRAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail · FRUniversité de Lille · FRUniversité Paris Cité · FRAssistance Publique – Hôpitaux de Paris · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-Hodgkin lymphoma (NHL), multiple myeloma and chronic lymphocytic leukemia are possibly related to environmental and/or occupational exposure. The primary objective of this study was to develop a questionnaire for screening patients with these blood disorders who might benefit from a specialized consultation for possible recognition of the disease as an occupational disease. The study included 205 subjects (male gender, 67.3%; mean age, 60 years; NHL, 78.5%). The questionnaire performed very satisfactorily in identifying the exposures most frequently retained by experts for their potential involvement in the occurrence of NHL. Its sensitivity and specificity in relation to the final expertise were 96% and 96% for trichloroethylene, 85% and 82% for benzene, 78% and 87% for solvents other than trichloroethylene and dichloromethane, 87% and 95% for pesticides, respectively. Overall, 15% of the subjects were invited to ask National Social Insurance for compensation as occupational disease. These declarations concerned exposure to pesticides (64%), solvents (trichloroethylene: 29%; benzene: 18%; other than chlorinated solvents: 18%) and sometimes multiple exposures. In conclusion, this questionnaire appears as a useful tool to identify NHL patients for a specialized consultation, in order to ask for compensation for occupational disease.

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Non-HodgkinOccupational DiseasesOccupational ExposureCase-Control StudiesHumansMaleMiddle AgedRisk FactorsSurveys and Questionnairesexposure to pesticidesexposure to solventsnon-Hodgkin lymphomaoccupational diseaseworkers’ compensation

Identifiers

PMID33920383
PMCPMC8068898
OpenAlexW3154178371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.